Synucleozid is a potent the SNCA mRNA inhibitor that encodes α-synuclein protein (IC50=1.5 μM), has the potential for the investigation of Parkinson’s disease.
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 is a selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07nM and 0.02 nM for hV2R and rV2R, respectively.
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm is a highly efficient, selective, and short-acting peptide V2 receptor agonist (V2R), with EC50s of hV2R and rV2R being 0.25 and 0.05 nM, respectively.